A Resource for Healthcare and Social Services Professionals
May 24, 2022
8:00 am–8:30 am ET
This training will review the basic pharmacology and clinical use of naltrexone for the treatment of alcohol use disorders. Injection techniques for XR naltrexone will also be discussed.
Via Zoom
AUD Series: These trainings will provide an overview of alcohol use disorders, evidence-based screening tools, brief negotiated interview (BNI) for alcohol consumption, management of AUD in the primary care setting, and medications for the treatment of alcohol use disorder.
This training will review the basic pharmacology and clinical use of naltrexone for the treatment of alcohol use disorders. Injection techniques for XR naltrexone will also be discussed.
Nurses, social workers, other clinical staff, and non-clinicians.
Boston Medical Center Grayken Center for Addiction, Massachusetts Department of Public Health, Bureau of Substance Addiction Services (DPH/BSAS).
Boston Medical Center grants 0.50 hours to all nurses who attend and complete the evaluation. Boston Medical Center is approved as a provider of continuing professional development by American Nurses Association, Massachusetts, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.
BMC Grayken Center of Addiction TTA has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7188. Programs that do not qualify for NBCC credit are clearly identified. BMC Grayken Center of Addiction TTAe is solely responsible for all aspects of the programs.
OBAT TTA is a program of Boston Medical Center (BMC), a 514-bed academic medical center located in Boston's historic South End and the largest safety-net hospital in New England.
